Cancer trials: money is not only currency of success

Alan Maynard's article ('Looking Askance', 19 November), on the cost-effectiveness of cancer services, was disappointing in its narrowness of approach.

You need to be an HSJ subscriber to read more


Subscribe to read the full article

With an HSJ subscription you’ll get access to:

  • Expert Briefing newsletters, covering nine topics and regions
  • Weekly Catch Up – a summary of the week’s most important stories
  • Unlimited access to
  • The HSJ app

Enquire about multi-user access